Rare diseases
Investigational molecules
Locations
Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma
ItalyStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
ItalyStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
ItalyStudy of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment
ItalyStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
ItalyStudy on Long-Term Safety and Effects of Apitegromab in Patients with Type 2 and TYPE 3 Spinal Muscular Atrophy Who Completed Previous Trials
ItalyStudy of OP-1250 for Treating Advanced or Metastatic ER+, HER2- Breast Cancer in Patients After Endocrine and CDK4/6 Inhibitor Therapy
ItalyStudy of Imlunestrant, Fulvestrant, Exemestane, and Abemaciclib for Patients with Advanced Estrogen Receptor Positive, HER2 Negative Breast Cancer
ItalyStudy of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery
ItalyStudy of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression
ItalyStudy of long-term safety of octreotide subcutaneous depot (CAM2029) in patients with acromegaly
ItalyStudy on Ribociclib, Topotecan, and Temozolomide for Children and Young Adults (12 months - 21 years) with Relapsed or Refractory Neuroblastoma and Solid Tumors
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
